@article{discovery1424290,
           pages = {167--172},
            note = {This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.},
          volume = {124},
         journal = {Nephron Clinical Practice},
            year = {2014},
           title = {Acute stroke thrombolysis in end-stage renal disease: a national survey of nephrologist opinion},
          number = {3-4},
           month = {February},
             url = {http://dx.doi.org/10.1159/000357155},
        abstract = {Systemic thrombolysis for acute ischaemic stroke is the standard of care in the UK. In the absence of trial data on the safety and efficacy of this treatment in patients with end-stage renal disease, we captured the views of UK nephrologists to highlight health care policy and research objectives.},
            issn = {1660-2110},
          author = {Power, A and Fogarty, D and Wheeler, DC},
        keywords = {Data Collection, Humans, Kidney Failure, Chronic, Nephrology, Patient Safety, Physician's Role, Stroke, Thrombolytic Therapy}
}